Literature DB >> 16737747

Mitochondrial dynamics and disease, OPA1.

Aurélien Olichon1, Emmanuelle Guillou, Cécile Delettre, Thomas Landes, Laetitia Arnauné-Pelloquin, Laurent J Emorine, Valérie Mils, Marlène Daloyau, Christian Hamel, Patrizia Amati-Bonneau, Dominique Bonneau, Pascal Reynier, Guy Lenaers, Pascale Belenguer.   

Abstract

The mitochondria are dynamic organelles that constantly fuse and divide. An equilibrium between fusion and fission controls the morphology of the mitochondria, which appear as dots or elongated tubules depending the prevailing force. Characterization of the components of the fission and fusion machineries has progressed considerably, and the emerging question now is what role mitochondrial dynamics play in mitochondrial and cellular functions. Its importance has been highlighted by the discovery that two human diseases are caused by mutations in the two mitochondrial pro-fusion genes, MFN2 and OPA1. This review will focus on data concerning the function of OPA1, mutations in which cause optic atrophy, with respect to the underlying pathophysiological processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16737747     DOI: 10.1016/j.bbamcr.2006.04.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  75 in total

Review 1.  Mitochondrial Dynamics and Heart Failure.

Authors:  A A Knowlton; T T Liu
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

2.  Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization.

Authors:  Ann Cassidy-Stone; Jerry E Chipuk; Elena Ingerman; Cheng Song; Choong Yoo; Tomomi Kuwana; Mark J Kurth; Jared T Shaw; Jenny E Hinshaw; Douglas R Green; Jodi Nunnari
Journal:  Dev Cell       Date:  2008-02       Impact factor: 12.270

3.  Dynamins at a glance.

Authors:  Jürgen A W Heymann; Jenny E Hinshaw
Journal:  J Cell Sci       Date:  2009-10-01       Impact factor: 5.285

Review 4.  Quality control of mitochondrial proteostasis.

Authors:  Michael J Baker; Takashi Tatsuta; Thomas Langer
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

Review 5.  Mitochondrial Proteolysis and Metabolic Control.

Authors:  Sofia Ahola; Thomas Langer; Thomas MacVicar
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

6.  The first direct activity assay for the mitochondrial protease OMA1.

Authors:  Julia Tobacyk; Nirmala Parajuli; Stephen Shrum; John P Crow; Lee Ann MacMillan-Crow
Journal:  Mitochondrion       Date:  2019-03-26       Impact factor: 4.160

7.  The membrane scaffold SLP2 anchors a proteolytic hub in mitochondria containing PARL and the i-AAA protease YME1L.

Authors:  Timothy Wai; Shotaro Saita; Hendrik Nolte; Sebastian Müller; Tim König; Ricarda Richter-Dennerlein; Hans-Georg Sprenger; Joaquin Madrenas; Mareike Mühlmeister; Ulrich Brandt; Marcus Krüger; Thomas Langer
Journal:  EMBO Rep       Date:  2016-10-13       Impact factor: 8.807

8.  Altered skeletal muscle mitochondrial biogenesis but improved endurance capacity in trained OPA1-deficient mice.

Authors:  F Caffin; A Prola; J Piquereau; M Novotova; D J David; A Garnier; D Fortin; M V Alavi; V Veksler; R Ventura-Clapier; F Joubert
Journal:  J Physiol       Date:  2013-09-16       Impact factor: 5.182

9.  Formation of cristae and crista junctions in mitochondria depends on antagonism between Fcj1 and Su e/g.

Authors:  Regina Rabl; Vincent Soubannier; Roland Scholz; Frank Vogel; Nadine Mendl; Andreja Vasiljev-Neumeyer; Christian Körner; Ravi Jagasia; Thomas Keil; Wolfgang Baumeister; Marek Cyrklaff; Walter Neupert; Andreas S Reichert
Journal:  J Cell Biol       Date:  2009-06-15       Impact factor: 10.539

10.  OPA1-related dominant optic atrophy is not strongly influenced by mitochondrial DNA background.

Authors:  Denis Pierron; Marc Ferré; Christophe Rocher; Arnaud Chevrollier; Pascal Murail; Didier Thoraval; Patrizia Amati-Bonneau; Pascal Reynier; Thierry Letellier
Journal:  BMC Med Genet       Date:  2009-07-20       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.